Job description: We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment and teamwork, and so can you. We are looking for a talented GMP Production professional to lead a team of Biotechnologists and achieve the production schedule whilst maintaining GMP, safety and environmental compliance. Oxford Biomedica’s Manufacturing Team is responsible for the production and aseptic fill and finish of vectors, for our clients and partners, to GMP standard. Your responsibilities in this role would be: Taking accountability for the performance and Line Management of a team of Biotechnologists Co-ordinating production activities and requirements with other departments in order to achieve the production schedule with minimal disruption to other activities within the facility, this will require to be on a ‘on call’ rota. Ensuring that all work within the manufacturing facility is carried out in compliance with the facilities GMP procedures. Acting as a Subject Matter Expert (SME)for facility SOP's and batch documentation, CAPA / Dev / Change Controls, and regulatory / customer GMP audits. Deputising for Production Manager approval on quality documents. Leading all manufacturing processes within the GMP facility. Trainer and SME on core manufacturing activities. Leading process/continuous improvement projects to increase the department’s efficiency. Promoting ownership and Continuous Improvement. Proposing and where required adopts new technologies to improve efficiency / reduce risk. Organising team training and review / approve training records. We are looking for: Graduate in a science-based subject, and/or experience of working to GMP standard within an aseptic environment. Knowledge of Lenti Viral Vector Manufacture is desirable. Previous biological/chemical manufacturing experience in an MHRA /FDA regulated environment. Demonstratable ability to lead and manage a team. Robust problem-solving skills with the ability to make informed decisions. Excellent verbal and written communication skills, with a strong knowledge of MS Office applications. Flexibility to work varying shift patterns (shift allowance payable). About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: Highly competitive total reward packages Wellbeing programmes Development opportunities Welcoming, friendly, supportive colleagues A diverse and inclusive working environment Our values are: Responsible, Responsive, Resilient, Respect State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.